Phytecs Expands Research Slate; Preclinical Data Indicates Its …

LOS ANGELES–(BUSINESS WIRE)–Phytecs
is expanding its preclinical research program on its novel fluorinated
cannabidiol, HUF-101, along with its family of related drug molecules
developed by noted medicinal chemist and Phytecs Director of Global
Research, Prof.
Raphael Mechoulam
of The Hebrew University of Jerusalem. A new
preclinical study found HUF-101 effective in mice models predictive of
anxiolytic, antidepressant, antipsychotic and anti-compulsive effects.
The University of São Paulo study led by Prof. Francisco S. Guimarães
entitled, “Fluorinated
Cannabidiol Derivatives: Enhancement of

... read more at: http://www.businesswire.com/news/home/20160809006103/en/Phytecs-Expands-Research-Slate-Preclinical-Data-Fluorinated

by